How would the use of Semaglutide impact the Chilean population? An estimated analysis following the SELECT trial approach

  • Fanny Petermann-Rocha
  • , Camilo Briones-Valdivieso
  • , Gabriela Nazar
  • , Daniela Sugg
  • , Daniel Reyes-Molina
  • , Carlos Celis-Morales
  • , Felipe Diaz-Toro
  • , Salil Deo

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1533-1536
Number of pages4
JournalDiabetes, Obesity and Metabolism
Volume28
Issue number2
DOIs
Publication statusPublished - Feb 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Semaglutide
  • obesity therapy
  • type 2 diabetes
  • weight control

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this